PASS Studies

What are PASS Studies? 

PASS studies (Post-Authorization Safety Studies) are research studies conducted after a drug or medical device has been approved and marketed to assess its long-term safety and effectiveness in the general population. These studies are designed to monitor real-world safety data, identify rare or delayed adverse events, and ensure that the benefits of a treatment continue to outweigh the risks over time. 

Why are PASS Studies important?

PASS studies are critical for maintaining drug safety and efficacy after market approval. By monitoring long-term outcomes and identifying safety risks in the general population, PASS studies ensure that health interventions remain beneficial and safe for all patients, improving public health and treatment outcomes. 

Interested in Target RWE's capabilities?

For detailed information on our solutions, please contact our team.